BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14680499)

  • 41. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
    Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of vascular endothelial growth factor, interleukin-18 and nitric oxide in patients with breast cancer: correlation with carbohydrate antigen 15.3.
    Metwally FM; El-mezayen HA; Ahmed HH
    Med Oncol; 2011 Dec; 28 Suppl 1():S15-21. PubMed ID: 20725807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
    Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
    Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of bFGF and VEGF in acute leukemia and its effects on HL-60 cell growth].
    Zhang WP; Chun XQ; Zhang YQ; Liang R; Li YH; Gao GX; Zhu HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):91-4. PubMed ID: 15748443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
    Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
    Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
    Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serum miR-103 as a potential diagnostic biomarker for breast cancer].
    Wang X; Wu X; Yan L; Shao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):631-4. PubMed ID: 22588912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
    Fuksiewicz M; Kowalska M; Kotowicz B; Rubach M; Chechlinska M; Pienkowski T; Kaminska J
    Clin Chem Lab Med; 2010 Oct; 48(10):1481-6. PubMed ID: 20578967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer?
    Granato AM; Frassineti GL; Giovannini N; Ballardini M; Nanni O; Maltoni R; Amadori D; Volpi A
    Tumour Biol; 2006; 27(6):302-8. PubMed ID: 17028465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expressions of vascular endothelial growth factor and basic fibroblast growth factor in the late stage of pressure ulcer].
    Dai YL; Pan YY; Sun Y; Cui FF; Zhang L; Xiao J; Jiang LP
    Zhonghua Shao Shang Za Zhi; 2012 Oct; 28(5):363-6. PubMed ID: 23290762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum VEGF and bFGF in patients with inflammatory bowel diseases.
    Kopanakis N; Saiti A; D'Avgerinos E; Masselou K; Simiri M; Mandaraka A; Vasiliadis G; Katergiannakis V
    Ann Ital Chir; 2014; 85(3):203-6. PubMed ID: 25073576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients.
    Porta C; Imarisio I; De Amici M; Bonomi L; Paglino C; Biscaldi E; Zimatore M; Sartore-Bianchi A; Danova M; Moratti R; Riccardi A
    Oncol Rep; 2005 Apr; 13(4):689-95. PubMed ID: 15756443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-acetylglucosaminidase, myeloperoxidase and vascular endothelial growth factor serum levels in breast cancer patients.
    Coelho BA; Belo AV; Andrade SP; Amorim WC; Uemura G; da Silva Filho AL
    Biomed Pharmacother; 2014 Mar; 68(2):185-9. PubMed ID: 24295784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
    Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
    Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum level of angiogenesis-related cytokins in patients with myelodysplastic syndrome].
    Zhao MQ; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):519-22. PubMed ID: 17605857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations.
    El-Raggal NM; El-Farrash RA; Saad AA; Attia EAS; Saafan HA; Shaaban IS
    Clin Appl Thromb Hemost; 2018 May; 24(4):663-668. PubMed ID: 28595487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.
    Linderholm BK; Lindh B; Beckman L; Erlanson M; Edin K; Travelin B; Bergh J; Grankvist K; Henriksson R
    Clin Breast Cancer; 2003 Dec; 4(5):340-7. PubMed ID: 14715109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.